NCT05557110View on ClinicalTrials.gov

Reduced-dose Chemotherapy Followed by Blinatumomab in Induction Therapy of Newly Diagnosed Non-elderly Ph-B-ALL

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

September 8, 2022

Primary Completion Date

January 5, 2024

Study Completion Date

March 31, 2024

Conditions
B Acute Lymphoblastic Leukemia
Interventions
DRUG

Blinatumomab

Reduced-intensity chemotherapy followed by Blinatumomab

Trial Locations (1)

215000

The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Suzhou

All Listed Sponsors
lead

Chen Suning

OTHER